Report cover image

Global Cyclophosphamide Injection Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 196 Pages
SKU # APRC20361441

Description

Summary

According to APO Research, The global Cyclophosphamide Injection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cyclophosphamide Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cyclophosphamide Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Cyclophosphamide Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Cyclophosphamide Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Cyclophosphamide Injection include Amneal Pharmaceuticals, Athenex, Aurobindo Pharma, Getwell Oncology, GLS Pharma, Ingenus, NorthStar Rx LLC, Zydus Cadila and Baxter, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cyclophosphamide Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Cyclophosphamide Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Cyclophosphamide Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cyclophosphamide Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Cyclophosphamide Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Cyclophosphamide Injection sales, projected growth trends, production technology, application and end-user industry.

Cyclophosphamide Injection Segment by Company

Amneal Pharmaceuticals
Athenex
Aurobindo Pharma
Getwell Oncology
GLS Pharma
Ingenus
NorthStar Rx LLC
Zydus Cadila
Baxter
Jiangsu Hengrui Medicine
Pfizer
Novartis
Cyclophosphamide Injection Segment by Type

High-Dose
Low-Dose
Cyclophosphamide Injection Segment by Application

AL Amyloidosis
Cancer
Autoimmune Diseases
Others
Cyclophosphamide Injection Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclophosphamide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyclophosphamide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclophosphamide Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Cyclophosphamide Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Cyclophosphamide Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cyclophosphamide Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Cyclophosphamide Injection Market by Type
1.2.1 Global Cyclophosphamide Injection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 High-Dose
1.2.3 Low-Dose
1.3 Cyclophosphamide Injection Market by Application
1.3.1 Global Cyclophosphamide Injection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 AL Amyloidosis
1.3.3 Cancer
1.3.4 Autoimmune Diseases
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Cyclophosphamide Injection Market Dynamics
2.1 Cyclophosphamide Injection Industry Trends
2.2 Cyclophosphamide Injection Industry Drivers
2.3 Cyclophosphamide Injection Industry Opportunities and Challenges
2.4 Cyclophosphamide Injection Industry Restraints
3 Global Market Growth Prospects
3.1 Global Cyclophosphamide Injection Revenue Estimates and Forecasts (2020-2031)
3.2 Global Cyclophosphamide Injection Revenue by Region
3.2.1 Global Cyclophosphamide Injection Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Cyclophosphamide Injection Revenue by Region (2020-2025)
3.2.3 Global Cyclophosphamide Injection Revenue by Region (2026-2031)
3.2.4 Global Cyclophosphamide Injection Revenue Market Share by Region (2020-2031)
3.3 Global Cyclophosphamide Injection Sales Estimates and Forecasts 2020-2031
3.4 Global Cyclophosphamide Injection Sales by Region
3.4.1 Global Cyclophosphamide Injection Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Cyclophosphamide Injection Sales by Region (2020-2025)
3.4.3 Global Cyclophosphamide Injection Sales by Region (2026-2031)
3.4.4 Global Cyclophosphamide Injection Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Cyclophosphamide Injection Revenue by Manufacturers
4.1.1 Global Cyclophosphamide Injection Revenue by Manufacturers (2020-2025)
4.1.2 Global Cyclophosphamide Injection Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Cyclophosphamide Injection Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Cyclophosphamide Injection Sales by Manufacturers
4.2.1 Global Cyclophosphamide Injection Sales by Manufacturers (2020-2025)
4.2.2 Global Cyclophosphamide Injection Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Cyclophosphamide Injection Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Cyclophosphamide Injection Sales Price by Manufacturers (2020-2025)
4.4 Global Cyclophosphamide Injection Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Cyclophosphamide Injection Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Cyclophosphamide Injection Manufacturers, Product Type & Application
4.7 Global Cyclophosphamide Injection Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Cyclophosphamide Injection Market CR5 and HHI
4.8.2 2024 Cyclophosphamide Injection Tier 1, Tier 2, and Tier 3
5 Cyclophosphamide Injection Market by Type
5.1 Global Cyclophosphamide Injection Revenue by Type
5.1.1 Global Cyclophosphamide Injection Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Cyclophosphamide Injection Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Cyclophosphamide Injection Revenue Market Share by Type (2020-2031)
5.2 Global Cyclophosphamide Injection Sales by Type
5.2.1 Global Cyclophosphamide Injection Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Cyclophosphamide Injection Sales by Type (2020-2031) & (K Units)
5.2.3 Global Cyclophosphamide Injection Sales Market Share by Type (2020-2031)
5.3 Global Cyclophosphamide Injection Price by Type
6 Cyclophosphamide Injection Market by Application
6.1 Global Cyclophosphamide Injection Revenue by Application
6.1.1 Global Cyclophosphamide Injection Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Cyclophosphamide Injection Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Cyclophosphamide Injection Revenue Market Share by Application (2020-2031)
6.2 Global Cyclophosphamide Injection Sales by Application
6.2.1 Global Cyclophosphamide Injection Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Cyclophosphamide Injection Sales by Application (2020-2031) & (K Units)
6.2.3 Global Cyclophosphamide Injection Sales Market Share by Application (2020-2031)
6.3 Global Cyclophosphamide Injection Price by Application
7 Company Profiles
7.1 Amneal Pharmaceuticals
7.1.1 Amneal Pharmaceuticals Comapny Information
7.1.2 Amneal Pharmaceuticals Business Overview
7.1.3 Amneal Pharmaceuticals Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Amneal Pharmaceuticals Cyclophosphamide Injection Product Portfolio
7.1.5 Amneal Pharmaceuticals Recent Developments
7.2 Athenex
7.2.1 Athenex Comapny Information
7.2.2 Athenex Business Overview
7.2.3 Athenex Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Athenex Cyclophosphamide Injection Product Portfolio
7.2.5 Athenex Recent Developments
7.3 Aurobindo Pharma
7.3.1 Aurobindo Pharma Comapny Information
7.3.2 Aurobindo Pharma Business Overview
7.3.3 Aurobindo Pharma Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Aurobindo Pharma Cyclophosphamide Injection Product Portfolio
7.3.5 Aurobindo Pharma Recent Developments
7.4 Getwell Oncology
7.4.1 Getwell Oncology Comapny Information
7.4.2 Getwell Oncology Business Overview
7.4.3 Getwell Oncology Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Getwell Oncology Cyclophosphamide Injection Product Portfolio
7.4.5 Getwell Oncology Recent Developments
7.5 GLS Pharma
7.5.1 GLS Pharma Comapny Information
7.5.2 GLS Pharma Business Overview
7.5.3 GLS Pharma Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 GLS Pharma Cyclophosphamide Injection Product Portfolio
7.5.5 GLS Pharma Recent Developments
7.6 Ingenus
7.6.1 Ingenus Comapny Information
7.6.2 Ingenus Business Overview
7.6.3 Ingenus Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Ingenus Cyclophosphamide Injection Product Portfolio
7.6.5 Ingenus Recent Developments
7.7 NorthStar Rx LLC
7.7.1 NorthStar Rx LLC Comapny Information
7.7.2 NorthStar Rx LLC Business Overview
7.7.3 NorthStar Rx LLC Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 NorthStar Rx LLC Cyclophosphamide Injection Product Portfolio
7.7.5 NorthStar Rx LLC Recent Developments
7.8 Zydus Cadila
7.8.1 Zydus Cadila Comapny Information
7.8.2 Zydus Cadila Business Overview
7.8.3 Zydus Cadila Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Zydus Cadila Cyclophosphamide Injection Product Portfolio
7.8.5 Zydus Cadila Recent Developments
7.9 Baxter
7.9.1 Baxter Comapny Information
7.9.2 Baxter Business Overview
7.9.3 Baxter Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Baxter Cyclophosphamide Injection Product Portfolio
7.9.5 Baxter Recent Developments
7.10 Jiangsu Hengrui Medicine
7.10.1 Jiangsu Hengrui Medicine Comapny Information
7.10.2 Jiangsu Hengrui Medicine Business Overview
7.10.3 Jiangsu Hengrui Medicine Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Jiangsu Hengrui Medicine Cyclophosphamide Injection Product Portfolio
7.10.5 Jiangsu Hengrui Medicine Recent Developments
7.11 Pfizer
7.11.1 Pfizer Comapny Information
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Pfizer Cyclophosphamide Injection Product Portfolio
7.11.5 Pfizer Recent Developments
7.12 Novartis
7.12.1 Novartis Comapny Information
7.12.2 Novartis Business Overview
7.12.3 Novartis Cyclophosphamide Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Novartis Cyclophosphamide Injection Product Portfolio
7.12.5 Novartis Recent Developments
8 North America
8.1 North America Cyclophosphamide Injection Market Size by Type
8.1.1 North America Cyclophosphamide Injection Revenue by Type (2020-2031)
8.1.2 North America Cyclophosphamide Injection Sales by Type (2020-2031)
8.1.3 North America Cyclophosphamide Injection Price by Type (2020-2031)
8.2 North America Cyclophosphamide Injection Market Size by Application
8.2.1 North America Cyclophosphamide Injection Revenue by Application (2020-2031)
8.2.2 North America Cyclophosphamide Injection Sales by Application (2020-2031)
8.2.3 North America Cyclophosphamide Injection Price by Application (2020-2031)
8.3 North America Cyclophosphamide Injection Market Size by Country
8.3.1 North America Cyclophosphamide Injection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Cyclophosphamide Injection Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Cyclophosphamide Injection Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Cyclophosphamide Injection Market Size by Type
9.1.1 Europe Cyclophosphamide Injection Revenue by Type (2020-2031)
9.1.2 Europe Cyclophosphamide Injection Sales by Type (2020-2031)
9.1.3 Europe Cyclophosphamide Injection Price by Type (2020-2031)
9.2 Europe Cyclophosphamide Injection Market Size by Application
9.2.1 Europe Cyclophosphamide Injection Revenue by Application (2020-2031)
9.2.2 Europe Cyclophosphamide Injection Sales by Application (2020-2031)
9.2.3 Europe Cyclophosphamide Injection Price by Application (2020-2031)
9.3 Europe Cyclophosphamide Injection Market Size by Country
9.3.1 Europe Cyclophosphamide Injection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Cyclophosphamide Injection Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Cyclophosphamide Injection Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
9.3.9 Nordic Countries
10 China
10.1 China Cyclophosphamide Injection Market Size by Type
10.1.1 China Cyclophosphamide Injection Revenue by Type (2020-2031)
10.1.2 China Cyclophosphamide Injection Sales by Type (2020-2031)
10.1.3 China Cyclophosphamide Injection Price by Type (2020-2031)
10.2 China Cyclophosphamide Injection Market Size by Application
10.2.1 China Cyclophosphamide Injection Revenue by Application (2020-2031)
10.2.2 China Cyclophosphamide Injection Sales by Application (2020-2031)
10.2.3 China Cyclophosphamide Injection Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Cyclophosphamide Injection Market Size by Type
11.1.1 Asia Cyclophosphamide Injection Revenue by Type (2020-2031)
11.1.2 Asia Cyclophosphamide Injection Sales by Type (2020-2031)
11.1.3 Asia Cyclophosphamide Injection Price by Type (2020-2031)
11.2 Asia Cyclophosphamide Injection Market Size by Application
11.2.1 Asia Cyclophosphamide Injection Revenue by Application (2020-2031)
11.2.2 Asia Cyclophosphamide Injection Sales by Application (2020-2031)
11.2.3 Asia Cyclophosphamide Injection Price by Application (2020-2031)
11.3 Asia Cyclophosphamide Injection Market Size by Country
11.3.1 Asia Cyclophosphamide Injection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Cyclophosphamide Injection Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Cyclophosphamide Injection Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Cyclophosphamide Injection Market Size by Type
12.1.1 SAMEA Cyclophosphamide Injection Revenue by Type (2020-2031)
12.1.2 SAMEA Cyclophosphamide Injection Sales by Type (2020-2031)
12.1.3 SAMEA Cyclophosphamide Injection Price by Type (2020-2031)
12.2 SAMEA Cyclophosphamide Injection Market Size by Application
12.2.1 SAMEA Cyclophosphamide Injection Revenue by Application (2020-2031)
12.2.2 SAMEA Cyclophosphamide Injection Sales by Application (2020-2031)
12.2.3 SAMEA Cyclophosphamide Injection Price by Application (2020-2031)
12.3 SAMEA Cyclophosphamide Injection Market Size by Country
12.3.1 SAMEA Cyclophosphamide Injection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Cyclophosphamide Injection Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Cyclophosphamide Injection Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Cyclophosphamide Injection Value Chain Analysis
13.1.1 Cyclophosphamide Injection Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Cyclophosphamide Injection Production Mode & Process
13.2 Cyclophosphamide Injection Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Cyclophosphamide Injection Distributors
13.2.3 Cyclophosphamide Injection Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.